Suntharesan Padmanathan - 01 Aug 2024 Form 4 Insider Report for Heliogen, Inc. (HLGN)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
05 Aug 2024, 17:41:39 UTC
Prior SEC filing
07 Aug 2023
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Deborah Chen, Attorney-in-Fact

Key filing fact

Suntharesan Padmanathan filed Form 4 for Heliogen, Inc. (HLGN) on 05 Aug 2024.

Key facts

  • This page summarizes Suntharesan Padmanathan's Form 4 filing for Heliogen, Inc. (HLGN).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 05 Aug 2024, 17:41.

Change

  • Previous filing in this sequence was filed on 07 Aug 2023.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

HLGN transaction

Common Stock

Award

Transaction value
$0
Shares
+2,142
Change %
+35%
Price
$0.000000
Shares after
8,266
Date
01 Aug 2024
Ownership
Direct
Footnotes
F1, F2, F3
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Consists of 2,142 restricted stock units ("RSUs") granted to the Reporting Person under the 2021 Equity Incentive Plan (the "Plan"), pursuant to the Amended and Restated Non-Employee Director Compensation Policy of the Issuer, vesting on the earlier of (i) August 1, 2025 and (ii) the day before the Issuer's next annual meeting of shareholders after the grant date, in each case, subject to the Reporting Person's continuous service as defined in the Plan through the vesting date. The RSUs are payable in an equivalent number of shares of common stock of the Issuer.

Footnote F2

On August 31, 2023, the Issuer effected a 1-for-35 reverse stock split (the "Reverse Stock Split") of its outstanding shares of Common Stock. The numbers of shares of Common Stock reported on this Form 4 have been adjusted to reflect the Reverse Split unless otherwise noted.

Footnote F3

Also includes 1,154 RSUs granted to the Reporting Person under the Plan vesting in three equal annual installments such that the RSUs are fully vested on December 31, 2024, subject to the Reporting Person's continuous service as defined in the Plan through each vesting date. The RSUs are payable in an equivalent number of shares of common stock of the Issuer.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .